Top compounds associated with response to AMPD3


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib CCLE pan-cancer AAC 0.15 0.002
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA SN-38 GDSC1000 pan-cancer AAC 0.1 0.003
mRNA Doxorubicin gCSI pan-cancer AAC -0.16 0.003
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.096 0.003
mRNA JNJ-26854165 GDSC1000 pan-cancer AAC 0.1 0.003
mRNA 5-FU CTRPv2 pan-cancer AAC -0.1 0.004
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.004
mRNA Erlotinib gCSI pan-cancer AAC 0.17 0.004
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
Download CSV